BLBin Lan

Bin Lan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bin Lan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Ruilong Kou

    Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, No. 20, Chazhong Road, Fuzhou City, 350004, Fujian Province, China

    5 shared publications
  • Yu Chen

    Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, No. 20, Chazhong Road, Fuzhou City, 350004, Fujian Province, China

    5 shared publications
  • Jinzhou Wang

    Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, No. 20, Chazhong Road, Fuzhou City, 350004, Fujian Province, China

    3 shared publications
  • Zhiwei Qin

    Department of Gastrointestinal Surgery 2 Section, The First Affiliated Hospital, Fujian Medical University, China

    3 shared publications
  • Chenyu Zhu

    First Affiliated Hospital of Dalian Medical University

    2 shared publications
  • Jiuhua Xu

    Department of Gastrointestinal Surgery 2 Section, The First Affiliated Hospital, Fujian Medical University

    2 shared publications

Latest Publications

  • Open Access

    Metrnl ameliorates ulcerative colitis by inhibiting NLRP3 inflammasome activation via ASC

    by Ruilong Kou, Yueming Xia, Wenqin Wei, Yu Chen, Jinzhou Wang, Zhiwei Qin, Guangwei Zhu, Liangsheng Lin, Dingming Zheng, Jianxin Ye, et al.

    Ulcerative colitis (UC) is characterized by the dysregulation of inflammatory pathways, leading to extensive tissue damage and chronic inflammation. NLRP3 inflammasome promotes inflammatory cytokine maturation and pyroptosis. Meteorin-like protein (Metrnl) has anti-inflammatory effects; however, its specific mechanisms in regulating these pathways remain unclear. This study investigated the effect of Metrnl on UC via regulation of the NLRP3 inflammasome through regulation of its key component, apoptosis-associated speck-like protein containing CARD (ASC). NCM460 and FHC cells were treated with TNF-α to establish a cell validation model. Cells with Metrnl interference or overexpression were intervened with three inflammasome activators (ATP, nigericin, or alum), and a caspase-1 inhibitor (belnacasan). The inflammatory factor levels, ASC mRNA and protein expressions, pyroptosis-related proteins, and inflammasome were detected. Interactions between ASC, Metrnl and inflammasome were determined by protein immunoprecipitation. UC models were constructed using wild-type and Metrnl knockout mice. Histopathological changes and differences in pyroptosis-related protein and inflammasome expressions were examined. Metrnl expression was significantly decreased in colitis, and the inflammatory factors IL-1β and LDH expressions increased at the cellular and animal levels, promoting ASC expression and pyroptosis, and activating the inflammasome. Metrnl interference accelerated inflammation and pyroptosis, which were reversed by Metrnl overexpression. Interactive relationships between Metrnl and ASC were noted. Metrnl may mediate ASC protein expression, and reduce IL-1β expression and pyroptosis in colon epithelial cells through the inhibition of ASC-NLRP3 binding. In vivo studies with DSS-induced colitis models confirmed the significance of these findings. After Metrnl knockout, the colon of normal mice was shorter, and Metrnl-/- UC mice showed more severe colon tissue damage, reduced goblet cells, increased inflammation, and accumulation of pyroptosis protein expression, indicating that Metrnl knockout increases susceptibility to UC. Metrnl interferes with key inflammatory signaling pathways in UC by inhibiting the interaction between ASC and NLRP3, suggesting its potential in UC treatment.


  • Open Access

    Identification of oxidative stress-associated biomarkers for inflammatory bowel disease through integrated machine learning and weighted gene co-expression network analysis

    by Ruilong Kou, Yihao Liu, Chenyu Zhu, Tao Lu, Yu Chen, Zhiwei Qin, Bin Lan

    Background: Inflammatory bowel disease (IBD) is a complex chronic intestinal inflammatory disorder. Oxidative stress (OS) is crucial in the pathogenesis of IBD by promoting inflammation and disrupting the intestinal epithelial barrier. Methods: Weighted gene co-expression network analysis and machine learning were applied to publicly available gene expression data to identify OS-related biomarkers for IBD. Receiver operating characteristic curve, immune infiltration analysis, and single-cell analysis were used to evaluate diagnostic performance and cellular localization. RT-qPCR and Western blotting were conducted to validate gene expression. Results: Three hub genes (LCN2, APP, and TNFSF4) demonstrated strong diagnostic accuracy (AUC: 0.781, 0.805, and 0.754, respectively) in the discovery cohort (GSE3365). Furthermore, external validation in three independent cohorts also confirmed the robust diagnostic performance of the three hub genes. These genes were enriched in OS and inflammatory pathways, strongly correlated with infiltration of macrophages M0, monocytes, and neutrophils (p<0.01), and were highly expressed in goblet cells, stem cells, and T cells. DSS model validation confirmed significant upregulation at mRNA and protein levels. Conclusion: These OS-associated genes represent novel molecular targets for precise diagnosis and personalized treatment of IBD. This finding highlights the interplay among OS, immune dysregulation, and inflammation in IBD pathogenesis.

  • Open Access

    Unveiling prognostic genes and regulatory mechanisms of stress granules in gastric cancers: an integrated analysis of bulk transcriptomics and single-cell RNA sequencing

    by Ruilong Kou, Chenyu Zhu, Yu Chen, Jinzhou Wang, Jiuhua Xu, Bin Lan, Zhiwei Qin

    Background: Gastric cancer (GC) is often associated with a poor prognosis, and the precise molecular mechanisms driving its pathogenesis are not yet fully characterized. Stress granules (SGs) are now understood to play a crucial role in tumor progression, yet the prognostic value of SG-related markers in GC remains unclear. This study aimed to identify SG-related prognostic genes, clarify their clinical and biological significance in GC, and validate their potential as predictive indicators for patient overall survival (OS). Methods: Single-cell and transcriptomic data for gastric cancer, along with genes related to stress granules (SGRGs), were acquired from public databases and literature. Candidate genes were identified by intersecting differentially expressed genes (DEGs) with SGRGs. Prognostic genes were identified through univariate Cox regression, and a risk score model was constructed. The model’s performance was validated in an independent cohort. Based on risk stratification, functional enrichment analysis, immune cell infiltration pattern assessment, and chemotherapy drug sensitivity analysis were conducted. Cell types expressing the prognostic genes were identified using single-cell RNA sequencing (scRNA-seq), and the related key cell clusters were identified. Results: SERPINE1 , CD36 , MMRN1 , and GRP were identified as prognostic genes. The risk model demonstrated good performance in predicting the survival status of GC patients. GSEA revealed that significantly enriched pathways included neuroactive ligand-receptor interaction and extracellular matrix (ECM)-receptor interaction pathways. CD36, MMRN1, and SERPINE1 demonstrated significant positive correlations with mast cells (correlation coefficients (r) > 0.3, P < 0.001). Chemotherapy drugs exhibited greater efficacy in high-risk GC patients. Moreover, endothelial cells were considered key cells and played a critical role in GC. Finally, SERPINE1 expression was associated with clinical features and prognosis in GC. Conclusion: In summary, we identified a four-gene SG-related signature strongly associated with prognosis in GC and constructed a predictive model with clinical potential. Our integrated analysis identified endothelial cells as a candidate population linked to the expression of these genes. These findings provide associative evidence linking SGs to GC outcomes and highlight potential targets for future mechanistic and therapeutic exploration.

  • Open Access

    Systemic dysregulation of the gut microenvironment plays a pivotal role in the onset and progression of inflammatory bowel disease

    by Ruilong Kou, Yonggang Guo, Zhiwei Qin, Xiaochen Xu, Yihao Liu, Wenqin Wei, Yu Chen, Zhiyuan Jian, Bin Lan

    Inflammatory bowel disease (IBD) represents a multifaceted, chronic inflammatory condition affecting the gastrointestinal tract, with its underlying pathophysiological mechanisms not yet fully elucidated. Recent research has underscored the pivotal role of the gut microenvironment, a complex ecological system, in the pathogenesis of IBD. This review systematically examines the interactions between gut microenvironment components and their roles in the pathogenesis of IBD. It is now understood that gut dysbiosis results in a decrease in beneficial microbiota, such as Faecalibacterium and Roseburia, along with an increase in pathogenic bacteria, including Adherent-invasive Escherichia coli (AIEC). This microbial imbalance results in a reduction in the production of beneficial metabolites, such as short-chain fatty acids, and the accumulation of detrimental metabolites, thereby directly disrupting the gut microbiome. The resultant gut dysbiosis leads to dysfunction in intestinal stem cells (ISCs) and a reduction in the expression of tight junction (TJ) proteins, thereby further compromising the integrity of the intestinal epithelial barrier. This dysfunction allows microorganisms and harmful metabolites to penetrate the barrier, reaching the submucosal layer, where they activate both innate and adaptive immune responses, thereby initiating a complex immune cascade. Over time, this process leads to a self-sustaining inflammatory cycle that culminates in chronic IBD and potentially contributes to the development of metabolic disorders. This paper examines this cycle, elucidating the interactions among gut microbiota dysbiosis, metabolite alterations, barrier dysfunction, and immune activation that drive the pathogenesis of IBD, while also critically assessing the limitations of current therapeutic strategies. Based on our understanding of the overarching dysregulation of the gut microenvironment, we propose a paradigm shift in IBD from “controlling inflammation” to “restoring intestinal homeostasis”, and from “single therapy” to “comprehensive intervention”. This integrated approach encompasses microbiome remodeling, metabolite intervention, reconstruction of the immune microenvironment, and repair of barrier function. Such a multidimensional and integrated therapeutic strategy promises to effectively disrupt the pathological feedback loop, restore gut homeostasis, and offer novel theoretical and clinical insights for the precise treatment of IBD and its progression.


  • Open Access

    NAT10 promotes gastric cancer progression by enhancing the N4-acetylcytidine modification of TNC mRNA

    by Yu Chen, Jinzhou Wang, Jiuhua Xu, Ruilong Kou, Bin Lan, Zhiwei Qin

    Gastric cancer (GC) is a very aggressive malignant tumor of the digestive system. Previous studies have shown that N-acetyltransferase 10 (NAT10) can regulate the N4-acetylcytidine (ac4C) modification of downstream mRNAs through certain pathways to promote the progression of various tumors. However, reports on the regulatory effects of NAT10 on GC are rare. This study aimed to explore the potential mechanism by which NAT10 regulated GC progression. Clinical samples were used to study the correlation between NAT10 expression and poor prognosis in patients with GC by univariate analysis and multivariate analysis. In vitro and in vivo assays were performed to assess the effects of NAT10 and Tenascin C (TNC) on the malignant biological behaviors of GC cells. Acetylated RNA immunoprecipitation sequencing was conducted to explore the role of NAT10 in ac4C modification in GC. mRNA stability and translation efficiency assays were performed to investigate the effect of changes in NAT10 expression on its target TNC. Analysis of clinical samples revealed that NAT10 expression was abnormally elevated and positively correlated with TNC expression in GC, and increased NAT10 expression led to poor overall survival. In vitro and in vivo experiments revealed that high NAT10 expression promoted the invasive and proliferative capacity of GC cells. Rescue experiments suggested that TNC played an important role in the above process. Mechanistically, the acetylation-based RNA immunoprecipitation sequencing and acetylated RNA immunoprecipitation qPCR results indicated that NAT10 regulated the level of ac4C modification by binding to specific regions in TNC mRNA, increasing mRNA stability and translation, upregulating TNC expression, further activating the TNC/Akt/TGF-β1 positive feedback loop. In summary, our results reveal that NAT10 plays a critical role in GC development by affecting TNC mRNA stability and translation efficiency, which ultimately activates the TNC/Akt/TGF-β1 positive feedback loop. This study is expected to provide a novel target and theoretical basis for improving the diagnosis and treatment of GC.


  • Open Access

    EB1089 promotes the expression of vitamin D receptor in the intestinal epithelial cell line HT-29 and reduces lipopolysaccharide-induced inflammatory response

    by Dong Lu, Minghui Yu, Lu Chen, Jianqiang Ye, Liquan Huang, Guangwei Zhu, Bin Lan

    Background: EB1089 is a vitamin D receptor (VDR) agonist that reduces the inflammatory response. The specific pathway through which the inflammatory response is reduced is unclear, and this study is intended to investigate its effect on the inflammatory response through an LPS (lipopolysaccharide)-induced inflammation model of the intestinal epithelial cell line HT-29. Methods: We divided HT-29 cells into a control group, LPS group, and LPS + EB1089 group. Cell proliferation was detected with a Cell Counting Kit-8 (CCK-8) kit, and the apoptosis rate was determined through flow cytometry, the lactate dehydrogenase (LDH), interleukin-18 (IL-18), and interleukin-1β (IL-1β) contents were measured with enzyme-linked immunosorbent assay (ELISA), and the expression levels of ASC, Caspase-1, NLRP3, VDR, TLR4, MYD88, NF-κB and other proteins in the cells were detected by western blot. Results: Pretreatment with EB1089 pretreatment reduced the LPS-induced apoptosis of HT-29 cells. LDH content was evidently lower in the LPS + EB1089 group than in the LPS group. The LDH content in the LPS + EB1089 group was evidently lower than that in the LPS group. The protein expression levels of ASC, Caspase-1, NLRP3, TLR4, MyD88, and NF-κB in the LPS group were evidently increased compared with those in the control group; however, the protein expression of VDR evidently decreased. The protein expression levels of Caspase-1, NLRP3, TLR4, MyD88, and NF-κB in the LPS + EB1089 group were evidently lower than those in the LPS group; however, the VDR protein expression evidently increased in the LPS + EB1089 group. Conclusions: EB1089 promoted the VDR expression and reduced the LPS induced inflammation in HT-29 cells.


    • 1 December 2005
      • Vol. 34  (12) , 801-2

    [Expression of polo like kinase1 and Ki-67 in gastric carcinoma].

    by Bin Lan, Bing-Ya Liu, Xue-Hua Chen, Ying Qu, Xiao-Qing Zhang, Qu Cai, Zheng-Gang Zhu